Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice.
about
Nanoways to overcome docetaxel resistance in prostate cancer.Feasibility of classical secondary hormonal therapies prior to docetaxel therapy in Japanese patients with castration-resistant prostate cancer: Multicenter retrospective study.Safety and Efficacy of First-Line Treatments for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Indirect Comparison.
P2860
Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostate-specific antigen resp ...... results of real life practice.
@en
Prostate-specific antigen resp ...... results of real life practice.
@nl
type
label
Prostate-specific antigen resp ...... results of real life practice.
@en
Prostate-specific antigen resp ...... results of real life practice.
@nl
prefLabel
Prostate-specific antigen resp ...... results of real life practice.
@en
Prostate-specific antigen resp ...... results of real life practice.
@nl
P2093
P2860
P356
P1476
Prostate-specific antigen resp ...... results of real life practice.
@en
P2093
Choung-Soo Kim
Chunwoo Lee
Dalsan You
Geehyun Song
Hanjong Ahn
In Gab Jeong
Jun Hyuk Hong
P2860
P304
P356
10.12954/PI.13024
P577
2013-09-27T00:00:00Z